554
Views
0
CrossRef citations to date
0
Altmetric
Brief Report

Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study – IL PSO (Italian landscape psoriasis)

, , , , , , ORCID Icon, , , ORCID Icon, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , & show all
Article: 2350760 | Received 23 Apr 2024, Accepted 29 Apr 2024, Published online: 07 May 2024